CML: The good, the better, and the difficult choices

Jorge Cortes

doi:10.1182/blood-2012-09-452789

CML: The good, the better, and the difficult choices

Jorge Cortes

Research output: Contribution to journal › Comment/debate › peer-review

4 Scopus citations

Abstract

In this issue of Blood, Radich and colleagues from 4 cooperative groups report on the results of a randomized study of dasatinib versus imatinib as initial treatment for patients with chronic phase chronic myeloid leukemia (CML).

Original language	English (US)
Pages (from-to)	3866-3867
Number of pages	2
Journal	Blood
Volume	120
Issue number	19
DOIs	https://doi.org/10.1182/blood-2012-09-452789
State	Published - Nov 8 2012
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2012-09-452789

Cite this

@article{38e0bb22d3934b8b88a1ba28f4b6d08d,

title = "CML: The good, the better, and the difficult choices",

abstract = "In this issue of Blood, Radich and colleagues from 4 cooperative groups report on the results of a randomized study of dasatinib versus imatinib as initial treatment for patients with chronic phase chronic myeloid leukemia (CML).",

author = "Jorge Cortes",

year = "2012",

month = nov,

day = "8",

doi = "10.1182/blood-2012-09-452789",

language = "English (US)",

volume = "120",

pages = "3866--3867",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "19",

}

TY - JOUR

T1 - CML

T2 - The good, the better, and the difficult choices

AU - Cortes, Jorge

PY - 2012/11/8

Y1 - 2012/11/8

N2 - In this issue of Blood, Radich and colleagues from 4 cooperative groups report on the results of a randomized study of dasatinib versus imatinib as initial treatment for patients with chronic phase chronic myeloid leukemia (CML).

AB - In this issue of Blood, Radich and colleagues from 4 cooperative groups report on the results of a randomized study of dasatinib versus imatinib as initial treatment for patients with chronic phase chronic myeloid leukemia (CML).

UR - http://www.scopus.com/inward/record.url?scp=84868593987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868593987&partnerID=8YFLogxK

U2 - 10.1182/blood-2012-09-452789

DO - 10.1182/blood-2012-09-452789

M3 - Comment/debate

C2 - 23144157

AN - SCOPUS:84868593987

SN - 0006-4971

VL - 120

SP - 3866

EP - 3867

JO - Blood

JF - Blood

IS - 19

ER -

CML: The good, the better, and the difficult choices

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this